Global Cell Culture Media Market Size & Outlook, 2023-2030
Global cell culture media market, 2018-2030 (US$M)
Related Markets
Global cell culture media market highlights
- The global cell culture media market generated a revenue of USD 4,725.1 million in 2023 and is expected to reach USD 10,699.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 12.4% by 2030.
- In terms of segment, serum-free media accounted for a revenue of USD 1,701.0 million in 2023.
- Serum-free Media is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 4,725.1 million |
| Market revenue in 2030 | USD 10,699.5 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Serum-free media |
| Fastest growing segment | Serum-free Media |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
Other key industry trends
- In terms of revenue, the North America accounted for 37.6% of the global cell culture media market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 81.0 million by 2030.
Serum-free media was the largest segment with a revenue share of 36% in 2023. Horizon Databook has segmented the Global cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
The biosimilars market is on the cusp of momentous growth. This growth is mainly due to the anticipated launch of several MAB biosimilars in the coming years as patents on significant drugs, such as trastuzumab (Herceptin from Roche), infliximab (Remicade from J& J), and Adalimumab (Humira from Abbott), are going to expire Emerging countries such as Venezuela, Brazil, Colombia, India, and Mexico have established regulations for biosimilar approval.
Russia is also developing a pathway for approval, as are other countries across Africa and Asia. The China FDA has also begun discussions on the development of a biosimilar approval procedure. Moreover, the reduction of manufacturing costs has become one of the most significant technological advantages for a biosimilar manufacturer. Therefore, the capability to imitate the biologically active molecule at the lowermost possible cost via cell culture has become important to efficient biosimilar development.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Media Market Scope
Cell Culture Media Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global cell culture media market size, by regions, 2018-2030 (US$M)
Top 10 countries: Cell culture media market size, 2023 (US$M)
Global cell culture media market share, by product, 2023 & 2030 (%, US$M)
Cell culture media market: Opportunity assessment by country
Global cell culture media market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
